| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 8 | |
| #2 | WIPO (World Intellectual Property Organization) | 5 | |
| #3 | Australia | 2 | |
| #4 | Canada | 2 | |
| #5 | China | 2 | |
| #6 | EPO (European Patent Office) | 2 | |
| #7 | Singapore | 2 | |
| #8 | New Zealand | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Measuring microorganism processes | |
| #2 | Analysing materials | |
| #3 | Therapeutic chemical compounds | |
| #4 | Medical preparations | |
| #5 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Watson James Douglas | 23 |
| #2 | Elton Clare | 13 |
| #3 | Musgrave David Rex | 13 |
| #4 | Forster Richard Llewellyn Sydney | 11 |
| #5 | Appleyard Kay Alison | 5 |
| #6 | Belanger Helene | 5 |
| #7 | White Damian Jay | 4 |
| #8 | Chalmet Kristen | 4 |
| #9 | Watson James D | 1 |
| #10 | Chalmet Kristin | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2014303027A1 | Gene expression profiling for the diagnosis of prostate cancer | |
| US2015252425A1 | Gene expression profiling for the diagnosis of prostate cancer | |
| CN104884960A | Methods for determining personalized treatment compositions for prostate cancer and breast cancer | |
| US2014005058A1 | Methods and materials for the diagnosis of prostate cancers | |
| WO2013070088A1 | Methods and materials for determining the efficacy of prostate cancer therapies | |
| US2013116142A1 | Methods and materials for the diagnosis of prostate cancers |